Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholder's Equity (Unaudited)

v3.21.2
Consolidated Statements of Stockholder's Equity (Unaudited) - USD ($)
$ in Thousands
Total
December 2019 Financing [Member]
May 2021 Public Offering [Member]
April 2020 Private Placement [Member]
LPC [Member]
Common stock [Member]
Common stock [Member]
Series B Convertible Preferred Stock [Member]
Common stock [Member]
Convertible Preferred Stock [Member]
Common stock [Member]
May 2021 Public Offering [Member]
Common stock [Member]
April 2020 Private Placement [Member]
Preferred stock [Member]
Preferred stock [Member]
Series B Convertible Preferred Stock [Member]
Additional paid-in capital [Member]
Additional paid-in capital [Member]
Series B Convertible Preferred Stock [Member]
Additional paid-in capital [Member]
Convertible Preferred Stock [Member]
Additional paid-in capital [Member]
December 2019 Financing [Member]
Additional paid-in capital [Member]
May 2021 Public Offering [Member]
Additional paid-in capital [Member]
April 2020 Private Placement [Member]
Additional paid-in capital [Member]
LPC [Member]
Accumulated other comprehensive income (loss) [Member]
Accumulated deficit [Member]
Beginning Balance at Dec. 31, 2019 $ 18,050         $ 41             $ 63,709             $ 4 $ (45,704)
Beginning Balance, Shares at Dec. 31, 2019           1,474,258         1,121                    
Stock-based compensation expense 302                       302                
Costs relating to financing and purchase agreement   $ (34)     $ (13)                     $ (34)     $ (13)    
Shares issued on conversion of preferred shares             $ 2             $ (2)              
Shares issued on conversion of preferred shares, Shares             93,379         (1,121)                  
Net loss (3,320)                                       (3,320)
Ending Balance at Mar. 31, 2020 14,985         $ 43             63,962             4 (49,024)
Ending Balance, Shares at Mar. 31, 2020           1,567,637                              
Beginning Balance at Dec. 31, 2019 18,050         $ 41             63,709             4 (45,704)
Beginning Balance, Shares at Dec. 31, 2019           1,474,258         1,121                    
Net loss (6,242)                                        
Ending Balance at Jun. 30, 2020 14,538         $ 51             66,429             4 (51,946)
Ending Balance, Shares at Jun. 30, 2020           1,937,703                              
Beginning Balance at Mar. 31, 2020 14,985         $ 43             63,962             4 (49,024)
Beginning Balance, Shares at Mar. 31, 2020           1,567,637                              
Stock-based compensation expense 308                       308                
Costs relating to financing and purchase agreement         $ (1)                           $ (1)    
Shares issued on conversion of preferred shares               $ 2             $ (2)            
Shares issued on exercise of warrants 589                       589                
Shares issued on exercise of warrants, Shares           89,281                              
Shares issued       $ 1,579           $ 6               $ 1,573      
Shares issued, Shares                   280,782                      
Adjustment of fractional shares on reverse stock split, Shares           3                              
Net loss (2,922)                                       (2,922)
Ending Balance at Jun. 30, 2020 14,538         $ 51             66,429             4 (51,946)
Ending Balance, Shares at Jun. 30, 2020           1,937,703                              
Beginning Balance at Dec. 31, 2020 37,286         $ 76             97,640             4 (60,434)
Beginning Balance, Shares at Dec. 31, 2020           6,111,735                              
Stock-based compensation expense 542                       542                
Shares issued on exercise of warrants 236                       236                
Shares issued on exercise of warrants, Shares           35,217                              
Shares issued 23                       23                
Shares issued, Shares           2,965                              
Net loss (7,999)                                       (7,999)
Ending Balance at Mar. 31, 2021 30,088         $ 76             98,441             4 (68,433)
Ending Balance, Shares at Mar. 31, 2021           6,149,917                              
Beginning Balance at Dec. 31, 2020 37,286         $ 76             97,640             4 (60,434)
Beginning Balance, Shares at Dec. 31, 2020           6,111,735                              
Net loss (19,310)                                        
Ending Balance at Jun. 30, 2021 40,854         $ 79             120,515             4 (79,744)
Ending Balance, Shares at Jun. 30, 2021           9,452,223                              
Beginning Balance at Mar. 31, 2021 30,088         $ 76             98,441             4 (68,433)
Beginning Balance, Shares at Mar. 31, 2021           6,149,917                              
Stock-based compensation expense 621                       621                
Shares issued on exercise of warrants 95                       95                
Shares issued on exercise of warrants, Shares           14,443                              
Shares issued 18   $ 21,343           $ 3       18       $ 21,340        
Shares issued, Shares           2,149     3,285,714                        
Net loss (11,311)                                       (11,311)
Ending Balance at Jun. 30, 2021 $ 40,854         $ 79             $ 120,515             $ 4 $ (79,744)
Ending Balance, Shares at Jun. 30, 2021           9,452,223